Otros idiomas Bio-Techne Corporation

Acciones

TECH

US09073M1045

Biotecnología e investigación médica

Tiempo real estimado Cboe BZX Otros sitios de cotización 18:05:46 15/12/2025			Variación 5 días	Varia. 1 de enero.
57,78 ^USD	-1,26 %		-4,11 %	-19,74 %

12/12	BIO-TECHNE CORPORATION : Recibe una recomendación de compra del Deutsche Bank Securities	ZM
12/12	BIO-TECHNE CORPORATION : Recibe una recomendación de compra del Deutsche Bank Securities	ZM

Otros idiomas

Bio-Techne Corporation Announces Strategic Collaboration Between One of Its Spatial Biology Brands, Lunaphore, and the Wyss Center for Bio and Neuroengineering	11/12
Bio-Techne's Lunaphore Brand, Wyss Center Geneva Partner Over Automated Workflow Development	11/12
Bio-Techne Partners with the Wyss Center Geneva to Advance Automated 3D Multiomics Technology and Accelerate Spatial Biology	11/12
Bio-Techne Launches the Enhanced Leo System Delivering Advanced Multiplexing and High-Throughput Protein Analysis	09/12
Bio-Techne Launches the Enhanced Leo™ System Delivering Advanced Multiplexing and High-Throughput Protein Analysis	09/12
Bio-Techne to Present at Upcoming Investor Conferences	25/11
Bio-Techne Licenses AI-Designed NovoBody Duo Molecules from Monod Bio to Expand Recombinant Protein Portfolio	19/11
Bio-Techne Licenses AI-Designed NovoBody Duo Molecules From Monod Bio	18/11
Bio-Techne announces licensing agreement with Monod Bio	18/11
Bio-Techne Licenses AI-Designed NovoBody™ Duo Molecules from Monod Bio to Expand Recombinant Protein Portfolio	18/11
Bio-Techne to Present at Upcoming Investor Conferences	06/11
Tranche Update on Bio-Techne Corporation's Equity Buyback Plan announced on May 6, 2025.	05/11
Bio-Techne Corporation Declares Dividend for the Quarter Ended September 30, 2025, Payable on November 28, 2025	05/11
Bio-Techne Corporation Reports Earnings Results for the First Quarter Ended September 30, 2025	05/11
Bio-Techne misses quarterly sales estimates on weak biotech demand	05/11
Bio-Techne Fiscal Q1 Adjusted Earnings Flat, Revenue Declines; Shares Down Pre-Bell	05/11
Bio-Techne Q1 revenue misses estimates	05/11
Earnings Flash (TECH) Bio-Techne Corporation Reports Q1 Revenue $286.6M, vs. FactSet Est of $291.3M	05/11
Earnings Flash (TECH) Bio-Techne Corporation Posts Q1 Adjusted EPS $0.42 per Share, vs. FactSet Est of $0.42	05/11
BIO-TECHNE DECLARES DIVIDEND	05/11
Bio-Techne Releases First Quarter Fiscal 2026 Results	05/11
Bio-Techne Corporation and Nucleai Announces the Presentation of Pivotal Data from the SECOMBIT Clinical Trial at the Society for Immunotherapy of Cancer 2025 Annual Meeting	04/11
AI-Powered Spatial Biology Workflow from Bio-Techne and Nucleai Enables Predictive Biomarker Discovery in Melanoma Patients	04/11
ScaleReady Announces a G-Rex® Grant has been awarded to Sonoma Biotherapeutics	03/11
Bio-Techne Launches ProximityScope Assay on the Bond Rx Platform from Leica Biosystems to Advance Spatial Protein-Protein Interactions Research	28/10

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripciones Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Bio-Techne Corporation

Acciones

TECH

US09073M1045

Biotecnología e investigación médica

Otros idiomas

Filtros